Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Montelukast Drug Market Growth 2022-2028

  • LP 4896859
  • 126 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Montelukast Drug will have significant change from previous year. According to our (LP Information) latest study, the global Montelukast Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Montelukast Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Montelukast Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Montelukast Drug market, reaching US$ million by the year 2028. As for the Europe Montelukast Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Montelukast Drug players cover Merck & Co., Teva, Mylan, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tablets

Oral Granules

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Drug Store

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck & Co.

Teva

Mylan

Glenmark Pharmaceuticals

Hikma Group

Sandoz

Torrent Pharmaceuticals

Lannett Company

Apotex

Dr. Reddys Laboratories

Aurobindo Pharma

Accord Healthcare

Hetero

Unimark

Ajanta Pharma

MACLEODS

Jubilant Pharma

Unichem Laboratories

Amneal Pharmaceuticals

Shanghai Anbison Lab

Perrigo

Cipla

CSPC Ouyi Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Montelukast Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Montelukast Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Montelukast Drug by Country/Region, 2017, 2022 & 2028

2.2 Montelukast Drug Segment by Type

2.2.1 Tablets

2.2.2 Oral Granules

2.3 Montelukast Drug Sales by Type

2.3.1 Global Montelukast Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Montelukast Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Montelukast Drug Sale Price by Type (2017-2022)

2.4 Montelukast Drug Segment by Application

2.4.1 Hospital

2.4.2 Drug Store

2.4.3 Others

2.5 Montelukast Drug Sales by Application

2.5.1 Global Montelukast Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Montelukast Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Montelukast Drug Sale Price by Application (2017-2022)

3 Global Montelukast Drug by Company

3.1 Global Montelukast Drug Breakdown Data by Company

3.1.1 Global Montelukast Drug Annual Sales by Company (2020-2022)

3.1.2 Global Montelukast Drug Sales Market Share by Company (2020-2022)

3.2 Global Montelukast Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Montelukast Drug Revenue by Company (2020-2022)

3.2.2 Global Montelukast Drug Revenue Market Share by Company (2020-2022)

3.3 Global Montelukast Drug Sale Price by Company

3.4 Key Manufacturers Montelukast Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Montelukast Drug Product Location Distribution

3.4.2 Players Montelukast Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Montelukast Drug by Geographic Region

4.1 World Historic Montelukast Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Montelukast Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Montelukast Drug Annual Revenue by Geographic Region

4.2 World Historic Montelukast Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Montelukast Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Montelukast Drug Annual Revenue by Country/Region

4.3 Americas Montelukast Drug Sales Growth

4.4 APAC Montelukast Drug Sales Growth

4.5 Europe Montelukast Drug Sales Growth

4.6 Middle East & Africa Montelukast Drug Sales Growth

5 Americas

5.1 Americas Montelukast Drug Sales by Country

5.1.1 Americas Montelukast Drug Sales by Country (2017-2022)

5.1.2 Americas Montelukast Drug Revenue by Country (2017-2022)

5.2 Americas Montelukast Drug Sales by Type

5.3 Americas Montelukast Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Montelukast Drug Sales by Region

6.1.1 APAC Montelukast Drug Sales by Region (2017-2022)

6.1.2 APAC Montelukast Drug Revenue by Region (2017-2022)

6.2 APAC Montelukast Drug Sales by Type

6.3 APAC Montelukast Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Montelukast Drug by Country

7.1.1 Europe Montelukast Drug Sales by Country (2017-2022)

7.1.2 Europe Montelukast Drug Revenue by Country (2017-2022)

7.2 Europe Montelukast Drug Sales by Type

7.3 Europe Montelukast Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Montelukast Drug by Country

8.1.1 Middle East & Africa Montelukast Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Montelukast Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Montelukast Drug Sales by Type

8.3 Middle East & Africa Montelukast Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Montelukast Drug

10.3 Manufacturing Process Analysis of Montelukast Drug

10.4 Industry Chain Structure of Montelukast Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Montelukast Drug Distributors

11.3 Montelukast Drug Customer

12 World Forecast Review for Montelukast Drug by Geographic Region

12.1 Global Montelukast Drug Market Size Forecast by Region

12.1.1 Global Montelukast Drug Forecast by Region (2023-2028)

12.1.2 Global Montelukast Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Montelukast Drug Forecast by Type

12.7 Global Montelukast Drug Forecast by Application

13 Key Players Analysis

13.1 Merck & Co.

13.1.1 Merck & Co. Company Information

13.1.2 Merck & Co. Montelukast Drug Product Offered

13.1.3 Merck & Co. Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co. Main Business Overview

13.1.5 Merck & Co. Latest Developments

13.2 Teva

13.2.1 Teva Company Information

13.2.2 Teva Montelukast Drug Product Offered

13.2.3 Teva Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Main Business Overview

13.2.5 Teva Latest Developments

13.3 Mylan

13.3.1 Mylan Company Information

13.3.2 Mylan Montelukast Drug Product Offered

13.3.3 Mylan Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Main Business Overview

13.3.5 Mylan Latest Developments

13.4 Glenmark Pharmaceuticals

13.4.1 Glenmark Pharmaceuticals Company Information

13.4.2 Glenmark Pharmaceuticals Montelukast Drug Product Offered

13.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Glenmark Pharmaceuticals Main Business Overview

13.4.5 Glenmark Pharmaceuticals Latest Developments

13.5 Hikma Group

13.5.1 Hikma Group Company Information

13.5.2 Hikma Group Montelukast Drug Product Offered

13.5.3 Hikma Group Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hikma Group Main Business Overview

13.5.5 Hikma Group Latest Developments

13.6 Sandoz

13.6.1 Sandoz Company Information

13.6.2 Sandoz Montelukast Drug Product Offered

13.6.3 Sandoz Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sandoz Main Business Overview

13.6.5 Sandoz Latest Developments

13.7 Torrent Pharmaceuticals

13.7.1 Torrent Pharmaceuticals Company Information

13.7.2 Torrent Pharmaceuticals Montelukast Drug Product Offered

13.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Torrent Pharmaceuticals Main Business Overview

13.7.5 Torrent Pharmaceuticals Latest Developments

13.8 Lannett Company

13.8.1 Lannett Company Company Information

13.8.2 Lannett Company Montelukast Drug Product Offered

13.8.3 Lannett Company Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Lannett Company Main Business Overview

13.8.5 Lannett Company Latest Developments

13.9 Apotex

13.9.1 Apotex Company Information

13.9.2 Apotex Montelukast Drug Product Offered

13.9.3 Apotex Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Apotex Main Business Overview

13.9.5 Apotex Latest Developments

13.10 Dr. Reddys Laboratories

13.10.1 Dr. Reddys Laboratories Company Information

13.10.2 Dr. Reddys Laboratories Montelukast Drug Product Offered

13.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Dr. Reddys Laboratories Main Business Overview

13.10.5 Dr. Reddys Laboratories Latest Developments

13.11 Aurobindo Pharma

13.11.1 Aurobindo Pharma Company Information

13.11.2 Aurobindo Pharma Montelukast Drug Product Offered

13.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Aurobindo Pharma Main Business Overview

13.11.5 Aurobindo Pharma Latest Developments

13.12 Accord Healthcare

13.12.1 Accord Healthcare Company Information

13.12.2 Accord Healthcare Montelukast Drug Product Offered

13.12.3 Accord Healthcare Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Accord Healthcare Main Business Overview

13.12.5 Accord Healthcare Latest Developments

13.13 Hetero

13.13.1 Hetero Company Information

13.13.2 Hetero Montelukast Drug Product Offered

13.13.3 Hetero Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hetero Main Business Overview

13.13.5 Hetero Latest Developments

13.14 Unimark

13.14.1 Unimark Company Information

13.14.2 Unimark Montelukast Drug Product Offered

13.14.3 Unimark Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Unimark Main Business Overview

13.14.5 Unimark Latest Developments

13.15 Ajanta Pharma

13.15.1 Ajanta Pharma Company Information

13.15.2 Ajanta Pharma Montelukast Drug Product Offered

13.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Ajanta Pharma Main Business Overview

13.15.5 Ajanta Pharma Latest Developments

13.16 MACLEODS

13.16.1 MACLEODS Company Information

13.16.2 MACLEODS Montelukast Drug Product Offered

13.16.3 MACLEODS Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 MACLEODS Main Business Overview

13.16.5 MACLEODS Latest Developments

13.17 Jubilant Pharma

13.17.1 Jubilant Pharma Company Information

13.17.2 Jubilant Pharma Montelukast Drug Product Offered

13.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Jubilant Pharma Main Business Overview

13.17.5 Jubilant Pharma Latest Developments

13.18 Unichem Laboratories

13.18.1 Unichem Laboratories Company Information

13.18.2 Unichem Laboratories Montelukast Drug Product Offered

13.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Unichem Laboratories Main Business Overview

13.18.5 Unichem Laboratories Latest Developments

13.19 Amneal Pharmaceuticals

13.19.1 Amneal Pharmaceuticals Company Information

13.19.2 Amneal Pharmaceuticals Montelukast Drug Product Offered

13.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Amneal Pharmaceuticals Main Business Overview

13.19.5 Amneal Pharmaceuticals Latest Developments

13.20 Shanghai Anbison Lab

13.20.1 Shanghai Anbison Lab Company Information

13.20.2 Shanghai Anbison Lab Montelukast Drug Product Offered

13.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Shanghai Anbison Lab Main Business Overview

13.20.5 Shanghai Anbison Lab Latest Developments

13.21 Perrigo

13.21.1 Perrigo Company Information

13.21.2 Perrigo Montelukast Drug Product Offered

13.21.3 Perrigo Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Perrigo Main Business Overview

13.21.5 Perrigo Latest Developments

13.22 Cipla

13.22.1 Cipla Company Information

13.22.2 Cipla Montelukast Drug Product Offered

13.22.3 Cipla Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Cipla Main Business Overview

13.22.5 Cipla Latest Developments

13.23 CSPC Ouyi Pharmaceutical

13.23.1 CSPC Ouyi Pharmaceutical Company Information

13.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Offered

13.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 CSPC Ouyi Pharmaceutical Main Business Overview

13.23.5 CSPC Ouyi Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Montelukast Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Montelukast Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Oral Granules

Table 5. Global Montelukast Drug Sales by Type (2017-2022) & (K Units)

Table 6. Global Montelukast Drug Sales Market Share by Type (2017-2022)

Table 7. Global Montelukast Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Montelukast Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Montelukast Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Montelukast Drug Sales by Application (2017-2022) & (K Units)

Table 11. Global Montelukast Drug Sales Market Share by Application (2017-2022)

Table 12. Global Montelukast Drug Revenue by Application (2017-2022)

Table 13. Global Montelukast Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Montelukast Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Montelukast Drug Sales by Company (2020-2022) & (K Units)

Table 16. Global Montelukast Drug Sales Market Share by Company (2020-2022)

Table 17. Global Montelukast Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Montelukast Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Montelukast Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Montelukast Drug Producing Area Distribution and Sales Area

Table 21. Players Montelukast Drug Products Offered

Table 22. Montelukast Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Montelukast Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Montelukast Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Montelukast Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Montelukast Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Montelukast Drug Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Montelukast Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Montelukast Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Montelukast Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Montelukast Drug Sales by Country (2017-2022) & (K Units)

Table 34. Americas Montelukast Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Montelukast Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Montelukast Drug Sales by Type (2017-2022) & (K Units)

Table 38. Americas Montelukast Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Montelukast Drug Sales by Application (2017-2022) & (K Units)

Table 40. Americas Montelukast Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Montelukast Drug Sales by Region (2017-2022) & (K Units)

Table 42. APAC Montelukast Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Montelukast Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Montelukast Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Montelukast Drug Sales by Type (2017-2022) & (K Units)

Table 46. APAC Montelukast Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Montelukast Drug Sales by Application (2017-2022) & (K Units)

Table 48. APAC Montelukast Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Montelukast Drug Sales by Country (2017-2022) & (K Units)

Table 50. Europe Montelukast Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Montelukast Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Montelukast Drug Sales by Type (2017-2022) & (K Units)

Table 54. Europe Montelukast Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Montelukast Drug Sales by Application (2017-2022) & (K Units)

Table 56. Europe Montelukast Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Montelukast Drug Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Montelukast Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Montelukast Drug Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Montelukast Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Montelukast Drug Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Montelukast Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Montelukast Drug

Table 66. Key Market Challenges & Risks of Montelukast Drug

Table 67. Key Industry Trends of Montelukast Drug

Table 68. Montelukast Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Montelukast Drug Distributors List

Table 71. Montelukast Drug Customer List

Table 72. Global Montelukast Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Montelukast Drug Sales Market Forecast by Region

Table 74. Global Montelukast Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Montelukast Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Montelukast Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Montelukast Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Montelukast Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Montelukast Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Montelukast Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Montelukast Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Montelukast Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Montelukast Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Montelukast Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Montelukast Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck & Co. Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck & Co. Montelukast Drug Product Offered

Table 94. Merck & Co. Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Merck & Co. Main Business

Table 96. Merck & Co. Latest Developments

Table 97. Teva Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Teva Montelukast Drug Product Offered

Table 99. Teva Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Teva Main Business

Table 101. Teva Latest Developments

Table 102. Mylan Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Mylan Montelukast Drug Product Offered

Table 104. Mylan Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Mylan Main Business

Table 106. Mylan Latest Developments

Table 107. Glenmark Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Glenmark Pharmaceuticals Montelukast Drug Product Offered

Table 109. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Glenmark Pharmaceuticals Main Business

Table 111. Glenmark Pharmaceuticals Latest Developments

Table 112. Hikma Group Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Hikma Group Montelukast Drug Product Offered

Table 114. Hikma Group Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Hikma Group Main Business

Table 116. Hikma Group Latest Developments

Table 117. Sandoz Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. Sandoz Montelukast Drug Product Offered

Table 119. Sandoz Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Sandoz Main Business

Table 121. Sandoz Latest Developments

Table 122. Torrent Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. Torrent Pharmaceuticals Montelukast Drug Product Offered

Table 124. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Torrent Pharmaceuticals Main Business

Table 126. Torrent Pharmaceuticals Latest Developments

Table 127. Lannett Company Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. Lannett Company Montelukast Drug Product Offered

Table 129. Lannett Company Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Lannett Company Main Business

Table 131. Lannett Company Latest Developments

Table 132. Apotex Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Apotex Montelukast Drug Product Offered

Table 134. Apotex Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Apotex Main Business

Table 136. Apotex Latest Developments

Table 137. Dr. Reddys Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Dr. Reddys Laboratories Montelukast Drug Product Offered

Table 139. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Dr. Reddys Laboratories Main Business

Table 141. Dr. Reddys Laboratories Latest Developments

Table 142. Aurobindo Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 143. Aurobindo Pharma Montelukast Drug Product Offered

Table 144. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Aurobindo Pharma Main Business

Table 146. Aurobindo Pharma Latest Developments

Table 147. Accord Healthcare Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 148. Accord Healthcare Montelukast Drug Product Offered

Table 149. Accord Healthcare Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Accord Healthcare Main Business

Table 151. Accord Healthcare Latest Developments

Table 152. Hetero Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 153. Hetero Montelukast Drug Product Offered

Table 154. Hetero Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Hetero Main Business

Table 156. Hetero Latest Developments

Table 157. Unimark Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 158. Unimark Montelukast Drug Product Offered

Table 159. Unimark Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Unimark Main Business

Table 161. Unimark Latest Developments

Table 162. Ajanta Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 163. Ajanta Pharma Montelukast Drug Product Offered

Table 164. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Ajanta Pharma Main Business

Table 166. Ajanta Pharma Latest Developments

Table 167. MACLEODS Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 168. MACLEODS Montelukast Drug Product Offered

Table 169. MACLEODS Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. MACLEODS Main Business

Table 171. MACLEODS Latest Developments

Table 172. Jubilant Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 173. Jubilant Pharma Montelukast Drug Product Offered

Table 174. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Jubilant Pharma Main Business

Table 176. Jubilant Pharma Latest Developments

Table 177. Unichem Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 178. Unichem Laboratories Montelukast Drug Product Offered

Table 179. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Unichem Laboratories Main Business

Table 181. Unichem Laboratories Latest Developments

Table 182. Amneal Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 183. Amneal Pharmaceuticals Montelukast Drug Product Offered

Table 184. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Amneal Pharmaceuticals Main Business

Table 186. Amneal Pharmaceuticals Latest Developments

Table 187. Shanghai Anbison Lab Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 188. Shanghai Anbison Lab Montelukast Drug Product Offered

Table 189. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Shanghai Anbison Lab Main Business

Table 191. Shanghai Anbison Lab Latest Developments

Table 192. Perrigo Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 193. Perrigo Montelukast Drug Product Offered

Table 194. Perrigo Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 195. Perrigo Main Business

Table 196. Perrigo Latest Developments

Table 197. Cipla Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 198. Cipla Montelukast Drug Product Offered

Table 199. Cipla Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 200. Cipla Main Business

Table 201. Cipla Latest Developments

Table 202. CSPC Ouyi Pharmaceutical Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors

Table 203. CSPC Ouyi Pharmaceutical Montelukast Drug Product Offered

Table 204. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 205. CSPC Ouyi Pharmaceutical Main Business

Table 206. CSPC Ouyi Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Montelukast Drug

Figure 2. Montelukast Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Montelukast Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Montelukast Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Montelukast Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Oral Granules

Figure 11. Global Montelukast Drug Sales Market Share by Type in 2021

Figure 12. Global Montelukast Drug Revenue Market Share by Type (2017-2022)

Figure 13. Montelukast Drug Consumed in Hospital

Figure 14. Global Montelukast Drug Market: Hospital (2017-2022) & (K Units)

Figure 15. Montelukast Drug Consumed in Drug Store

Figure 16. Global Montelukast Drug Market: Drug Store (2017-2022) & (K Units)

Figure 17. Montelukast Drug Consumed in Others

Figure 18. Global Montelukast Drug Market: Others (2017-2022) & (K Units)

Figure 19. Global Montelukast Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Montelukast Drug Revenue Market Share by Application in 2021

Figure 21. Montelukast Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Montelukast Drug Revenue Market Share by Company in 2021

Figure 23. Global Montelukast Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Montelukast Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Montelukast Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Montelukast Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Montelukast Drug Sales 2017-2022 (K Units)

Figure 28. Americas Montelukast Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Montelukast Drug Sales 2017-2022 (K Units)

Figure 30. APAC Montelukast Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Montelukast Drug Sales 2017-2022 (K Units)

Figure 32. Europe Montelukast Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Montelukast Drug Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Montelukast Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Montelukast Drug Sales Market Share by Country in 2021

Figure 36. Americas Montelukast Drug Revenue Market Share by Country in 2021

Figure 37. United States Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Montelukast Drug Sales Market Share by Region in 2021

Figure 42. APAC Montelukast Drug Revenue Market Share by Regions in 2021

Figure 43. China Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Montelukast Drug Sales Market Share by Country in 2021

Figure 50. Europe Montelukast Drug Revenue Market Share by Country in 2021

Figure 51. Germany Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Montelukast Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Montelukast Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Montelukast Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Montelukast Drug in 2021

Figure 64. Manufacturing Process Analysis of Montelukast Drug

Figure 65. Industry Chain Structure of Montelukast Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390